HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Falsini, B. Articles by Mainster, M. A. Search for Related Content PubMed PubMed Citation Articles by Falsini, B. Articles by Mainster, M. A.

Monitoring Retinal Function during Transpupillary Thermotherapy for Occult Choroidal Neovascularization in Age-Related Macular Degeneration

¹From the Institute of Ophthalmology, Catholic University of S. Cuore, Rome, Italy; ²Iridex Corporation, Mountain View, California; and the ³Department of Ophthalmology, University of Kansas Medical Center, Kansas City, Kansas.

PURPOSE. To use focal electroretinography to evaluate changes in retinal function during transpupillary thermotherapy (TTT) for neovascular age-related macular degeneration (ARMD).

METHODS. Sixteen eyes of 16 patients with ARMD with occult choroidal neovascularization (CNV) were studied. A 630-nm photocoagulator aiming beam was modified for use as a 41-Hz square-wave focal electroretinogram (fERG) stimulus. The stimulus was presented on a light-adapting background by a Goldmann-type lens (visual angle, 18°; mean luminance, 50 cd/m²). fERGs were continuously monitored before, during, and after TTT for occult CNV. The amplitude and phase of the fERG’s fundamental harmonic were measured.

RESULTS. No suprathreshold or adverse clinical events occurred during the course of the study. fERG amplitude decreased transiently during TTT (23% ± 9% [SE]; P < 0.05). The decrease in amplitude was greatest 16 to 20 seconds and 32 to 40 seconds after the onset of TTT. It was followed by a recovery to baseline amplitude during TTT (48 to 60 seconds after TTT was begun). Within 60 seconds after TTT was completed, fERG amplitude was within the range of baseline. TTT did not alter the fERG phase. Mean fERG amplitudes and phases recorded 1 week and 1 month after TTT were comparable to mean pretreatment levels.

CONCLUSIONS. fERG amplitude decreases transiently during TTT, despite the absence of ophthalmoscopically apparent lesions. Intraoperative amplitude depression may result from an adaptation effect to laser light energy and/or hyperthermia, resulting in desensitization of cone photoreceptors and bipolar cells. Treatment sites are electrophysiologically functional 1 month after TTT. Detailed parametric study of a larger patient group is needed to determine whether fERG testing is potentially useful for monitoring and perhaps for controlling and optimizing TTT for choroidal neovascularization.

This article has been cited by other articles:

				Y. Shimada and M. Horiguchi Changes in Multifocal Electroretinograms Induced by Transpupillary Thermotherapy Arch Ophthalmol, August 1, 2005; 123(8): 1066 - 1072. [Abstract] [Full Text] [PDF]

				Y. Ming, P. V. Algvere, A. Odergren, L. Berglin, I. van der Ploeg, S. Seregard, and A. Kvanta Subthreshold Transpupillary Thermotherapy Reduces Experimental Choroidal Neovascularization in the Mouse without Collateral Damage to the Neural Retina Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1969 - 1974. [Abstract] [Full Text] [PDF]